Search Results - Ou SH
- Showing 1 - 2 results of 2
-
1
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond by Ou SH
Published 2011Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era? by Ou SH, Soo RA
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book